Bausch Health Companies Inc.

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• HEALTH C2 refused lines

  Unauthorized nutrient content or health claim

  The label or labeling appeared to carry a nutrient content claim or health claim that is not authorized.

• NCONTACT2 refused lines

  No U.S. adverse event contact on supplement label

  The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.

• NUTRIT LBL2 refused lines

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Bausch Health Companies Inc.

Is Bausch Health Companies Inc. on an FDA import alert?

No listing for Bausch Health Companies Inc. appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Canada page.

Has FDA refused shipments from Bausch Health Companies Inc.?

Yes. FDA refused 2 shipment lines from Bausch Health Companies Inc. between October 19, 2016 and October 26, 2016. The most recent, on October 26, 2016, was vitamin, n.e.c., charged as NCONTACT (no u.s. adverse event contact on supplement label).

Why did FDA refuse Bausch Health Companies Inc.'s shipments?

The most frequent charges are HEALTH C (unauthorized nutrient content or health claim, 2 lines) and NCONTACT (no u.s. adverse event contact on supplement label, 2 lines).

What is Bausch Health Companies Inc.'s FEI number?

Bausch Health Companies Inc.'s FDA Establishment Identifier (FEI) is 3002807186.